Pharmaceutical companies by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 pharmaceutical companies ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- ZAR 87.7T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | ZAR 172.8B | ZAR 1,143.08 | 5.47% up | 107% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | ZAR 142.4B | ZAR 2,053.97 | 1.92% up | 13% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | ZAR 83B | ZAR 1,474.22 | 1.93% down | 113% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | ZAR 143B | ZAR 2,190.16 | 1.65% up | 46% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | ZAR 148.6B | ZAR 5,315.93 | 0.83% up | 61% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | ZAR 124.2B | ZAR 891.71 | 0.11% down | 20% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | ZAR 80.1B | ZAR 481.15 | 3.26% up | 64% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | ZAR 103.3B | ZAR 5,162.03 | 1.66% up | 43% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | ZAR 165.5B | ZAR 1,742.97 | 7.50% up | 286% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | ZAR 135.3B | ZAR 805.03 | 2.49% up | 58% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | ZAR 78.6B | ZAR 718.19 | 1.15% down | 88% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | ZAR 262.1B | ZAR 1,345.64 | 1.38% up | 17% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | ZAR 83B | ZAR 236.60 | 1.44% down | 403% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | ZAR 84.5B | ZAR 485.82 | 0.93% up | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | ZAR 104B | ZAR 1,592.87 | 0.23% up | 31% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | ZAR 83.7B | ZAR 872.44 | 1.21% down | 44% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | ZAR 112.5B | ZAR 1,658.41 | 0.38% down | 241% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | ZAR 86.9B | ZAR 1,039.65 | 0.34% down | 20% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | ZAR 159.1B | ZAR 6,848.14 | 6.10% down | 24% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | ZAR 273.1B | ZAR 4,255.37 | 2.29% up | 37% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | ZAR 128.8B | ZAR 1,176.70 | 2.83% down | 8% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | ZAR 105.9B | ZAR 749.04 | 0.81% up | 10% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | ZAR 90.9B | ZAR 2,154.65 | 0.77% down | 233% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | ZAR 205.6B | ZAR 1,061.25 | 4.95% up | 11% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | ZAR 68.5B | ZAR 500.60 | 1.41% down | 169% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | ZAR 232.3B | ZAR 464.82 | 4.04% up | 20% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | ZAR 454.5B | ZAR 2,071.69 | 1.63% down | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | ZAR 484.4B | ZAR 668.50 | 0.08% down | 90% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | ZAR 121.8B | ZAR 2,315.38 | 1.46% down | 7% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | ZAR 54.4B | ZAR 280.67 | 0.81% up | 42% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | ZAR 129.1B | ZAR 1,643.68 | 0.01% down | 126% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | ZAR 145.3B | ZAR 181.64 | 1.50% down | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | ZAR 126.4B | ZAR 1,444.15 | 1.78% up | 27% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | ZAR 307.2B | ZAR 4,683.64 | 0.07% down | 28% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | ZAR 426.9B | ZAR 10,023.16 | 0.71% down | 23% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | ZAR 607.7B | ZAR 1,495.65 | 3.67% up | 29% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | ZAR 346.9B | ZAR 2,589.83 | 4.25% down | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | ZAR 109.7B | ZAR 2,699.92 | 0.95% down | 31% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | ZAR 131.7B | ZAR 377.97 | 3.55% up | 83% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | ZAR 404.4B | ZAR 352.74 | 0.20% down | 96% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | ZAR 216.3B | ZAR 259.50 | 1.52% up | 5% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | ZAR 849.3B | ZAR 727.87 | 1.18% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | ZAR 2.77T | ZAR 486.27 | 1.17% down | 14% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | ZAR 2.12T | ZAR 1,036.28 | 2.27% down | 34% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | ZAR 685.3B | ZAR 1,191.91 | 0.41% up | 78% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | ZAR 1.69T | ZAR 16,374.07 | 1.08% down | 36% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | ZAR 2.36T | ZAR 9,318.24 | 0.93% up | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | ZAR 545.7B | ZAR 885.05 | 1.44% down | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | ZAR 797.8B | ZAR 6,984.67 | 2.21% down | 17% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | ZAR 3.14T | ZAR 1,814.95 | 0.29% up | 17% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | ZAR 5.9T | ZAR 2,391.25 | 3.49% down | 51% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | ZAR 8.76T | ZAR 4,954.89 | 2.09% down | 26% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | ZAR 99.5B | ZAR 146.13 | 2.03% down | 1% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | ZAR 3.01T | ZAR 682.07 | 3.03% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | ZAR 21.37T | ZAR 23,987.92 | 1.95% down | 35% up | ||
| 56 | GSKGSK · Health Care | 0.81% | ZAR 1.69T | ZAR 842.36 | 1.02% down | 6% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | ZAR 11.39T | ZAR 4,732.64 | 1.75% down | 38% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | ZAR 1.96T | ZAR 815.58 | 0.72% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | ZAR 5.07T | ZAR 2,684.45 | 2.39% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | ZAR 4.8T | ZAR 3,095.70 | 1.73% down | 2% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | ZAR 1.18T | ZAR 367.86 | 1.64% down | 54% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2828 ZAR).
Questions and answers
Which pharmaceutical companies rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 pharmaceutical companies ranked by short interest as of the 30 Oct 2026 settlement date.
How many pharmaceutical companies are in this ranking?
61 are ranked by short interest.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by short interest have a combined market value of ZAR 87.7T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceutical companies by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.